Actinium Pharmaceuticals, Inc. (Delaware) (ATNM): Price and Financial Metrics
ATNM Price/Volume Stats
| Current price | $1.39 | 52-week high | $10.24 |
| Prev. close | $1.42 | 52-week low | $1.33 |
| Day low | $1.38 | Volume | 286,400 |
| Day high | $1.46 | Avg. volume | 444,624 |
| 50-day MA | $1.76 | Dividend yield | N/A |
| 200-day MA | $5.48 | Market Cap | 43.36M |
ATNM Stock Price Chart Interactive Chart >
Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) Company Bio
Actinium Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted payload immunotherapeutics for the treatment of advanced cancers. The companys targeted radio immunotherapy products are based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting Actinium-225 and Bismuth-213, and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. The company was founded in 2000 and is based in New York City, New York.
ATNM Price Returns
| 1-mo | -26.06% |
| 3-mo | -30.85% |
| 6-mo | -83.65% |
| 1-year | -68.55% |
| 3-year | -81.27% |
| 5-year | -78.36% |
| YTD | -72.64% |
| 2023 | -52.30% |
| 2022 | 77.20% |
| 2021 | -22.95% |
| 2020 | 19.43% |
| 2019 | -44.18% |
Loading social stream, please wait...